HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.

Abstract
Psoriasis is a chronic recurrent skin inflammatory disease, and inhibition of inflammation may be an effective means of treating psoriasis. The flavonoid genistein has a clear anti-inflammatory effect. However, the anti-psoriatic effects of genistein and their underlying mechanisms remain unclear. In this study, we investigated the effects of genistein on imiquimod (IMQ)-induced psoriasis-like skin lesions in vivo and explored the mechanisms underlying those effects in vitro. It was found that genistein can significantly improve IMQ-induced pathological scores of cutaneous skin lesions in mice, reduce epidermal thickness, and inhibit the expression of inflammatory factors,including interleukin (IL)-1β, IL-6, tumour necrosis factor-alpha (TNF-α), chemokine ligand 2 (CCL2), IL-17 and IL-23. In vitro studies, genistein inhibited the proliferation of human keratinocyte HaCaT cells and inhibited the expression of inflammatory factors in a dose-dependent manner which induced by TNFα. Further researches showed that genistein could also significantly inhibit phosphorylated STAT3 (pSAT3) expression in IMQ mice dorsal skin and in TNF-α-induced HaCaT cells. The inhibitory effect of genistein on the expression of IL-6, IL-23 and TNF-α was weakened after Stat3 siRNA in HaCaT cells. Genistein could also significantly inhibit TNF-α induced the nuclear translocation of NF-κB, and inhibit the phosphorylation of I-kBα (pI-kBα). After combining with NF-κB blocker BAY 11-7082, the effect of genistein down-regulate the expression of TNF-α and VEGFA was attenuated in HaCaT cells. The results suggest that genistein may be developed for the treatment of psoriasis lesions.
AuthorsAilin Wang, Jianan Wei, Chuanjian Lu, Haiming Chen, Xiaoqin Zhong, Yue Lu, Leng Li, Haiding Huang, Zhenhua Dai, Ling Han
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 69 Pg. 270-278 (Apr 2019) ISSN: 1878-1705 [Electronic] Netherlands
PMID30743203 (Publication Type: Journal Article)
CopyrightCopyright © 2019. Published by Elsevier B.V.
Chemical References
  • Anti-Inflammatory Agents
  • Cytokines
  • Inflammation Mediators
  • NF-kappa B
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Vascular Endothelial Growth Factor A
  • siroamide
  • vascular endothelial growth factor A, mouse
  • Heme
  • Genistein
  • Imiquimod
Topics
  • Animals
  • Anti-Inflammatory Agents (therapeutic use)
  • Cell Line
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Genistein (therapeutic use)
  • Heme (analogs & derivatives)
  • Humans
  • Imiquimod
  • Inflammation Mediators (metabolism)
  • Keratinocytes (drug effects, physiology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B (metabolism)
  • Psoriasis (drug therapy)
  • STAT3 Transcription Factor (genetics, metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: